Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Lellouche

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Open Forum Infectious Diseases|September 13, 2021
Increased Capsule Thickness and Hypermotility Are Traits of Carbapenem-Resistant <i>Acinetobacter baumannii</i> ST3 Strains Causing Fulminant InfectionNadya Rakovitsky, Jonathan Lellouche, Debby Ben David, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 15, 2021
The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgeryTomer Hoffman, Jonathan Lellouche, Amir Nutman, et al.
Antimicrobial Resistance and Infection Control|June 18, 2020
A silent outbreak of vancomycin-resistant Enterococcus faecium in a neonatal intensive care unitRonella Marom, Dror Mandel, Alon Haham, et al.
Infectious Diseases (London, England)|October 4, 2021
High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patientsRegev Cohen, Talya Finn, Frida Babushkin, et al.
Clinical and Translational Science|July 2, 2024
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomesVincent Aranzana-Climent, Wisse van Os, Amir Nutman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 13, 2021
In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infectionsAmir Nutman, Elizabeth Temkin, Jonathan Lellouche, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 7, 2020
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomesAmir Nutman, Jonathan Lellouche, Elizabeth Temkin, et al.
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant OrganismsYaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Open Forum Infectious Diseases|September 13, 2021
Increased Capsule Thickness and Hypermotility Are Traits of Carbapenem-Resistant <i>Acinetobacter baumannii</i> ST3 Strains Causing Fulminant InfectionNadya Rakovitsky, Jonathan Lellouche, Debby Ben David, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 15, 2021
The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgeryTomer Hoffman, Jonathan Lellouche, Amir Nutman, et al.
Antimicrobial Resistance and Infection Control|June 18, 2020
A silent outbreak of vancomycin-resistant Enterococcus faecium in a neonatal intensive care unitRonella Marom, Dror Mandel, Alon Haham, et al.
Infectious Diseases (London, England)|October 4, 2021
High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patientsRegev Cohen, Talya Finn, Frida Babushkin, et al.
Clinical and Translational Science|July 2, 2024
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomesVincent Aranzana-Climent, Wisse van Os, Amir Nutman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 13, 2021
In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infectionsAmir Nutman, Elizabeth Temkin, Jonathan Lellouche, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 7, 2020
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomesAmir Nutman, Jonathan Lellouche, Elizabeth Temkin, et al.
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant OrganismsYaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Pageof 5